We conclude that the interleukin-6-FoxO1 pathway in SMC is a molecular mechanism by which perinatal obesity programs the bronchial and vascular structure and function, thereby driving CLD development. This evidence concerns the gene FOXO1 and congenital secretory chloride diarrhea 1.